LataMed AI Surpasses 1,000 Platform Subscribers as It Develops Mobile Healthcare Apps for Apple and Google Stores
LataMed AI Corp. announced it has surpassed 1,000 early-stage platform subscribers while advancing development of mobile healthcare applications for the Apple App Store and Google Play, targeting underserved markets in Latin America.
LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced Tuesday that it has surpassed 1,000 early-stage platform subscribers as it continues to develop a suite of mobile healthcare applications for the Apple App Store and Google Play Store. The milestone reflects growing interest in the company's telehealth ecosystem, which is designed to address fragmented healthcare access in emerging markets, particularly Latin America.
The company said its applications under development are intended to support telehealth, healthcare communication, patient engagement, provider coordination, emergency response, and AI-assisted healthcare initiatives. These efforts are part of LataMed AI's broader strategy to build scalable digital healthcare infrastructure for underserved regions where access to coordination and digital tools is limited.
Management stated that certain applications are being prepared for anticipated future submission to the Apple App Store and Google Play Store, pending continued development, internal testing, platform review processes, and regulatory considerations. The company emphasized that the applications and related platform technologies remain under active development and have not yet been fully commercialized or broadly deployed.
“We are continuing to advance development of our mobile healthcare application ecosystem with the goal of expanding accessibility and healthcare connectivity through both Apple and Android mobile platforms,” said Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp. “Surpassing 1,000 early-stage users represents an encouraging milestone as we continue refining and expanding our broader digital healthcare infrastructure initiatives.”
The company believes that continued onboarding activity and user engagement may provide valuable operational feedback as development progresses and additional platform functionality is evaluated and refined. LataMed AI's broader technology initiatives remain focused on scalable healthcare infrastructure solutions intended to support developing markets where healthcare coordination and digital tools are often fragmented or unavailable.
For more information, visit the company’s website at https://latamed.ai, follow its official Instagram page at https://www.instagram.com/latamedai, or review its filings with the U.S. Securities and Exchange Commission at www.sec.gov.
No assurance can be provided regarding the timing of any public release, App Store or Google Play availability, regulatory progression, commercialization initiatives, future platform functionality, or operational success of the applications or related technologies, the company cautioned.